Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02658240 · ClinicalTrials.gov registry record · NA

Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration

A NA study of Postoperative Pain, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02658240 is a NA study of Postoperative Pain that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02658240, a NA study of Postoperative Pain, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.

Conditions Studied

Interventions

  • DRUG Epinephrine
  • DRUG Ropivacaine

Study Locations (1)

Texas

  • UTSW Parkland Health Hospital System - Dallas

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-04-05
Est. Completion 2017-12-16
Phase NA

What the Registry Record Tells You About NCT02658240

The ClinicalTrials.gov registry entry for NCT02658240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (74% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Epinephrine is the first listed.

NCT02658240 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02658240 about?

NCT02658240 is a clinical study titled "Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration". This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.

What is the current status of trial NCT02658240?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-04-05. Estimated completion is 2017-12-16.

What conditions does trial NCT02658240 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT02658240?

The interventions under investigation include: Epinephrine (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT02658240?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02658240 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.